Eliot Forster

Insider Reports History

Location
Carmiel
Signature
/s/ Joseph R. Magnas, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Eliot Forster:

Company Role Class Num Shares Value Price $ Report Date Ownership
Protalix BioTherapeutics, Inc. Director Common Stock 7,500 $12,075 $1.61 03 Sep 2025 By Trust
Protalix BioTherapeutics, Inc. Director Stock Options (Right to Buy) 15,000 03 Sep 2025 Direct
F-star Therapeutics, Inc. PRESIDENT AND CEO, Director Common Stock 0 $7.12 08 Mar 2023 Direct
F-star Therapeutics, Inc. PRESIDENT AND CEO, Director Stock Option (right to buy) 0 08 Mar 2023 Direct

Insider Reports Filed by Eliot Forster

Symbol Company Period Transactions Value $ Form Type Role Filing Time
PLX Protalix BioTherapeutics, Inc. 03 Sep 2025 2 $0 4 Director 04 Sep 2025, 17:00
PLX Protalix BioTherapeutics, Inc. 14 Sep 2023 1 $0 4 Director 15 Sep 2023, 16:46
PLX Protalix BioTherapeutics, Inc. 14 Sep 2023 0 $0 3 Director 15 Sep 2023, 16:45
/report/000089924323007669-forster-eliot-2023-03-08 F-star Therapeutics, Inc. 08 Mar 2023 5 -$3,001,343 4 PRESIDENT AND CEO, Director 09 Mar 2023, 08:20
/report/000120919122044007-forster-eliot-2022-07-29 F-star Therapeutics, Inc. 29 Jul 2022 3 +$28,707 4 President and CEO, Director 02 Aug 2022, 21:08
/report/000120919122022313-forster-eliot-2022-03-31 F-star Therapeutics, Inc. 31 Mar 2022 1 $0 4 President and CEO, Director 04 Apr 2022, 16:07
/report/000120919122002918-forster-eliot-2022-01-09 F-star Therapeutics, Inc. 09 Jan 2022 1 $0 4 President and CEO, Director 11 Jan 2022, 16:27